Iradimed (IRMD) Notes Payables (2013)
Iradimed (IRMD) reported Notes Payables of $6333.0 for Q4 2013.
Iradimed (IRMD) Notes Payables (2013) Analysis & Trends
Iradimed (IRMD) has 1 years of Notes Payables data on file, last reported at $6333.0 in Q4 2013.
- Notes Payables for Q4 2013 came in at $6333.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2013 was $6333.0 (changed N/A YoY), and the FY2013 annual result was $6333.0, changed N/A from the prior year.
- Notes Payables held at $6333.0 in Q4 2013 per IRMD's latest filing.
- Over five years, Notes Payables peaked at $6333.0 in Q4 2013 and troughed at $6333.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Iradimed | 1.18 Bn | 1.12 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 6,333.00 |